New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Metformin cuts insulin resistance and chances of kidney disease in young, obese rats

Metformin cuts insulin resistance and chances of kidney disease in young, obese rats

byAmerican Physiological SocietyAbstract. Credit:American Journal of Physiology-Renal Physiology(2023). DOI: 10.1152/ajprenal.00078.2023Improving insulin resistance with metformin, a
Diabetes & Endocrinology January 18,2024
Metformin cuts insulin resistance and chances of kidney disease in young, obese rats

Metformin cuts insulin resistance and chances of kidney disease in young, obese rats

byAmerican Physiological SocietyAbstract. Credit:American Journal of Physiology-Renal Physiology(2023). DOI: 10.1152/ajprenal.00078.2023Improving insulin resistance with metformin, a
Diabetes & Endocrinology January 18,2024
Metabolic signature can help predict which smokers will develop type 2 diabetes

Metabolic signature can help predict which smokers will develop type 2 diabetes

byDiabetologiaCredit: Unsplash/CC0 Public DomainNew research being presented at this year'sAnnual Meeting of The European Association for the Study of Diabetes (EASD)in Hamburg (
Diabetes & Endocrinology January 18,2024
Metabolic signature can help predict which smokers will develop type 2 diabetes

Metabolic signature can help predict which smokers will develop type 2 diabetes

byDiabetologiaCredit: Unsplash/CC0 Public DomainNew research being presented at this year'sAnnual Meeting of The European Association for the Study of Diabetes (EASD)in Hamburg (
Diabetes & Endocrinology January 18,2024
AI and machine learning can successfully diagnose polycystic ovary syndrome

AI and machine learning can successfully diagnose polycystic ovary syndrome

byNational Institutes of HealthSelection process of the studies. Article selection flow chart for studies related to AI/ML and PCOS according to Preferred Reporting Items for Systematic Reviews
Diabetes & Endocrinology January 18,2024
AI and machine learning can successfully diagnose polycystic ovary syndrome

AI and machine learning can successfully diagnose polycystic ovary syndrome

byNational Institutes of HealthSelection process of the studies. Article selection flow chart for studies related to AI/ML and PCOS according to Preferred Reporting Items for Systematic Reviews
Diabetes & Endocrinology January 18,2024
Q&A: Hot flashes, vaginal dryness: Is endocrine therapy worth it for breast cancer?

Q&A: Hot flashes, vaginal dryness: Is endocrine therapy worth it for breast cancer?

by Leslie Orr,University of Rochester Medical CenterAnna Weiss, MD. Credit: University of Rochester Medical CenterCancer treatment is riddled with pros and cons, trade-offs. During October, brea
Q & A January 18,2024
Q&A: Hot flashes, vaginal dryness: Is endocrine therapy worth it for breast cancer?

Q&A: Hot flashes, vaginal dryness: Is endocrine therapy worth it for breast cancer?

by Leslie Orr,University of Rochester Medical CenterAnna Weiss, MD. Credit: University of Rochester Medical CenterCancer treatment is riddled with pros and cons, trade-offs. During October, brea
Q & A January 18,2024
Researchers define normal natriuretic peptide level range across lifespan of healthy US population

Researchers define normal natriuretic peptide level range across lifespan of healthy US population

by Anna Jones,University of Alabama at BirminghamAge-specific NT-proBNP concentrations stratified by age and race and ethnicity. Credit:JACC: Heart Failure(2023). DOI: 10.1016/j.jchf
Diabetes & Endocrinology January 18,2024
Researchers define normal natriuretic peptide level range across lifespan of healthy US population

Researchers define normal natriuretic peptide level range across lifespan of healthy US population

by Anna Jones,University of Alabama at BirminghamAge-specific NT-proBNP concentrations stratified by age and race and ethnicity. Credit:JACC: Heart Failure(2023). DOI: 10.1016/j.jchf
Diabetes & Endocrinology January 18,2024
Integrative analysis reveals metabolic switch in aging astrocytes

Integrative analysis reveals metabolic switch in aging astrocytes

by Impact Journals LLCKEGG pathway enrichment analysis of astrocyte differential hub genes suggests a metabolic switch from aerobic glycolysis to oxidative phosphorylation during aging. Credit:A
Diabetes & Endocrinology January 18,2024
Integrative analysis reveals metabolic switch in aging astrocytes

Integrative analysis reveals metabolic switch in aging astrocytes

by Impact Journals LLCKEGG pathway enrichment analysis of astrocyte differential hub genes suggests a metabolic switch from aerobic glycolysis to oxidative phosphorylation during aging. Credit:A
Diabetes & Endocrinology January 18,2024
YBX1 as a key regulator of mitochondrial pyruvate uptake

YBX1 as a key regulator of mitochondrial pyruvate uptake

by Frontiers JournalsYBX1 resides in the mitochondrial IMS. (a) Representative images of colocalization of YBX1 and PDHA1 in MDA-MB-231, MHCC-97H, and HEK293T cells. Red indicates YBX1 and green indic
Diabetes & Endocrinology January 18,2024
YBX1 as a key regulator of mitochondrial pyruvate uptake

YBX1 as a key regulator of mitochondrial pyruvate uptake

by Frontiers JournalsYBX1 resides in the mitochondrial IMS. (a) Representative images of colocalization of YBX1 and PDHA1 in MDA-MB-231, MHCC-97H, and HEK293T cells. Red indicates YBX1 and green indic
Diabetes & Endocrinology January 18,2024
Study finds link between seasons and eating habits

Study finds link between seasons and eating habits

byUniversity of CopenhagenCredit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.08.005The number of hours of light exposure we experience affects how we eat and how we burn energy.
Diabetes & Endocrinology January 18,2024
Study finds link between seasons and eating habits

Study finds link between seasons and eating habits

byUniversity of CopenhagenCredit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2023.08.005The number of hours of light exposure we experience affects how we eat and how we burn energy.
Diabetes & Endocrinology January 18,2024
Breastfeeding alters infant gut in ways that boost brain development, may improve test scores: Study

Breastfeeding alters infant gut in ways that boost brain development, may improve test scores: Study

by Lisa Marshall,University of Colorado at BoulderConfirmed metabolites observed across feeding groups in at least 50% of samples at 1- and 6-months in the HILIC and C18 chromatography columns.
Diabetes & Endocrinology January 18,2024
Breastfeeding alters infant gut in ways that boost brain development, may improve test scores: Study

Breastfeeding alters infant gut in ways that boost brain development, may improve test scores: Study

by Lisa Marshall,University of Colorado at BoulderConfirmed metabolites observed across feeding groups in at least 50% of samples at 1- and 6-months in the HILIC and C18 chromatography columns.
Diabetes & Endocrinology January 18,2024
Scientists discover arginine drives metabolic reprogramming to promote tumor growth in liver cancer

Scientists discover arginine drives metabolic reprogramming to promote tumor growth in liver cancer

byUniversity of BaselTumor organoids (green/blue) are used as a model to study the metabolic changes in liver cell cancer. Credit: Dr. Sandro Nuciforo, Department of Biomedicine, University of B
Diabetes & Endocrinology January 18,2024
Scientists discover arginine drives metabolic reprogramming to promote tumor growth in liver cancer

Scientists discover arginine drives metabolic reprogramming to promote tumor growth in liver cancer

byUniversity of BaselTumor organoids (green/blue) are used as a model to study the metabolic changes in liver cell cancer. Credit: Dr. Sandro Nuciforo, Department of Biomedicine, University of B
Diabetes & Endocrinology January 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com